Pieris Pharmaceuticals Income Taxes 1970-1969 | PVLA

Pieris Pharmaceuticals income taxes from 1970 to 1969. Income taxes can be defined as the total amount of income tax expense for the given period.
Pieris Pharmaceuticals Annual Income Taxes
(Millions of US $)
Pieris Pharmaceuticals Quarterly Income Taxes
(Millions of US $)
Sector Industry Market Cap Revenue
Medical MED-BIOMED/GENE $0.016B $0.043B
Pieris Pharmaceuticals, Inc. is a biopharmaceutical company. The Company's drug technology consists of Anticalin(R) to treat cancer, severe asthma, anemia and other medical conditions. Pieris Pharmaceuticals, Inc. is based in Freising-Weihenstephan, Germany.
Stock Name Country Market Cap PE Ratio
NPK (NPKI) United States $0.626B 27.85
Performant Healthcare (PHLT) United States $0.245B 0.00
FTAC Emerald Acquisition (FLDD) United States $0.158B 0.00
Swiftmerge Acquisition (ANNA) United States $0.042B 0.00
Insight Acquisition (AMOD) United States $0.023B 0.00
Hanryu Holdings (GITS) South Korea $0.017B 0.00
LQR House (YHC) United States $0.011B 0.00
ATIF Holdings (ZBAI) China $0.009B 0.00
Lion Electric (LEVGQ) Canada $0.000B 0.00